Electromedical Technologies, Inc
EMEDOTCHealthcare · Surgical & Medical Instruments & Apparatus · DE · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY23 | FY22 | FY21 | FY20 | FY19 | |
|---|---|---|---|---|---|
| Revenue | $1.3M | $1.1M | $907,362 | $737,958 | $829,737 |
| Operating income | −$2.1M | −$1.6M | −$3.8M | −$3.2M | −$1.7M |
| Net income | −$2.6M | −$3.5M | −$8.5M | −$3.9M | −$1.7M |
| Total assets | $748,383 | $1.4M | $1.4M | $1.4M | $902,866 |
| Total liabilities | $3.6M | $3.6M | $2.1M | $2.7M | $3.1M |
| Equity | −$2.9M | −$2.2M | −$722,503 | −$1.3M | −$2.2M |
| EPS (diluted) | $0.00 | $-0.03 | $-0.24 | $-0.20 | — |
| Shares out. | 463.3M | 105.0M | 87.7M | 27.2M | 17.9M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2023- Operating margin
- −153.1%
- Net margin
- −195.8%
- Return on equity
- 91.9%
- Return on assets
- −352.9%
- Return on capital (ROCE)
- —
- Liabilities / assets
- 483.9%
- Debt / equity
- —
- Book value / share
- $-0.01
- Revenue growth (YoY)
- 17.3%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2023- Altman Z″ (distress)
- -164.52distress
- Accruals / assets
- −163.5%clean
- Piotroski F-Score
- 2/9weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 3 severe● 4 warning● 3 good- Negative shareholder equity
- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating losses (negative operating margin)
- Reported a net loss
- High leverage (liabilities > 70% of assets)
- Negative operating cash flow
- Strong return on equity (>15%)
- Revenue is growing year-over-year
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Kmissed a reporting deadline ↗Mar 31, 2025
- NT 10-Qmissed a reporting deadline ↗Nov 14, 2024
- NT 10-Qmissed a reporting deadline ↗May 15, 2024
- NT 10-Kmissed a reporting deadline ↗Apr 3, 2024
- NT 10-Qmissed a reporting deadline ↗Nov 15, 2023
- NT 10-Qmissed a reporting deadline ↗Aug 14, 2023
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Hymers Iii R. LeslieDirector | Feb 6, 2023 | Grant | 35.0M | $0.01 |
| Benson LeeDirector | Nov 2, 2022 | Grant | 1.7M | $0.01 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| Jan 30, 2026 | 107,222 | 1.0 | +100.0% |
| Dec 31, 2025 | 99,100 | 1.0 | +100.0% |
| Sep 30, 2025 | 150,000 | 1.0 | +100.0% |
| Jul 15, 2025 | 697 | 1.0 | +100.0% |
| May 30, 2025 | 20,000 | 1.0 | -80.0% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Amended charter or bylawsJul 24, 2024
- Changed auditorMay 21, 2024
- Other material eventApr 2, 2024
- Director / officer changeJul 5, 2023
- Regulation FD disclosureApr 20, 2023
- Entered a material agreement · Completed an acquisition or dispositionMar 21, 2023
- Modified shareholder rights · Change in control · Director / officer change · Amended charter or bylawsFeb 1, 2023
- Director / officer changeDec 23, 2022
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- 15-12GFORM 15-12GJul 14, 2025
- NT 10-KFORM NT 10-KMar 31, 2025
- 10-QFORM 10-QNov 19, 2024
- NT 10-QFORM NT 10-QNov 14, 2024
- UPLOADOct 18, 2024
- 10-K/AFORM 10-K/AOct 16, 2024
- UPLOADOct 1, 2024
- 10-QAug 14, 2024
- 8-K/AFORM 8-K/AAug 9, 2024
- 8-KFORM 8-KJul 24, 2024
- 10-QJun 14, 2024
- 8-KFORM 8-KMay 21, 2024
- NT 10-QMay 15, 2024
- 10-KMay 1, 2024
- NT 10-KApr 3, 2024
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.